Impact of COVID-19 lockdown on progressive multiple sclerosis patients

INTRODUCTION: The COVID-19 pandemic caused major changes in the lifestyle and in the access to health services worldwide. Progressive multiple sclerosis (pMS) patients are a vulnerable population at high risk of disability worsening. OBJECTIVE AND METHODS: The objective of this study was to assess t...

Descripción completa

Detalles Bibliográficos
Autores principales: Vercellino, Marco, Bosa, Chiara, Alteno, Anastasia, Schillaci, Valentina, Petracca, Manuel, Marasciulo, Stella, Cavalla, Paola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Covid-19
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8786196/
https://www.ncbi.nlm.nih.gov/pubmed/35075574
http://dx.doi.org/10.1007/s10072-022-05909-z
Descripción
Sumario:INTRODUCTION: The COVID-19 pandemic caused major changes in the lifestyle and in the access to health services worldwide. Progressive multiple sclerosis (pMS) patients are a vulnerable population at high risk of disability worsening. OBJECTIVE AND METHODS: The objective of this study was to assess the health outcomes of COVID-19 lockdown in a cohort of 225 pMS patients. RESULTS: Worsening of neurological disability (19.7%) and fatigue (32.4%), depression (30.4%), and weight increase (28.3%) were observed in pMS patients during lockdown, along with discontinuation of regular physical exercise (47.1%) and of physical therapy (59.3%). CONCLUSION: These results highlight the adverse impact, on pMS patients, of the public health measures implemented for the containment of the pandemic. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s10072-022-05909-z.

Ejemplares similares